Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Role of superoxide production in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.

Koyama T, Tawa M, Yamagishi N, Tsubota A, Sawano T, Ohkita M, Matsumura Y.

Eur J Pharmacol. 2013 Jul 5;711(1-3):36-41. doi: 10.1016/j.ejphar.2013.04.019. Epub 2013 Apr 27.

PMID:
23628722
2.

Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.

Tawa M, Fukumoto T, Ohkita M, Matsumura Y.

Eur J Pharmacol. 2008 Sep 4;591(1-3):182-8. doi: 10.1016/j.ejphar.2008.06.039. Epub 2008 Jun 14.

PMID:
18586023
3.

Protective effects of 17beta-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow through the non-genomic estrogen receptor/nitric oxide-mediated pathway in the rat heart.

Fukumoto T, Tawa M, Yamashita N, Ohkita M, Matsumura Y.

Eur J Pharmacol. 2013 Jan 15;699(1-3):74-80. doi: 10.1016/j.ejphar.2012.11.042. Epub 2012 Dec 5.

PMID:
23219795
4.

Effects of ET(A) and ET(B) receptor blockade on post-ischemic cardiac dysfunction and norepinephrine overflow in isolated rat hearts.

Yamamoto S, Matsumoto N, Kanazawa M, Fujita M, Takaoka M, Matsumura Y.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S394-7.

PMID:
15838330
5.

Sex differences in postischemic cardiac dysfunction and norepinephrine overflow in rat heart: the role of estrogen against myocardial ischemia-reperfusion damage via an NO-mediated mechanism.

Fukumoto T, Yamashita N, Tawa M, Ohkita M, Matsumura Y.

J Cardiovasc Pharmacol. 2012 Sep;60(3):269-75. doi: 10.1097/FJC.0b013e31825e2e57.

PMID:
22635075
6.

Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.

Yamamoto S, Matsumoto N, Kanazawa M, Fujita M, Takaoka M, Gariepy CE, Yanagisawa M, Matsumura Y.

Circulation. 2005 Jan 25;111(3):302-9. Epub 2005 Jan 10.

7.

TEMPOL, a membrane-permeable radical scavenger, attenuates gastric mucosal damage induced by ischemia/reperfusion: a key role for superoxide anion.

Abdallah DM, El-Abhar HS, Abdel-Aziz DH.

Eur J Pharmacol. 2009 Jan 28;603(1-3):93-7. doi: 10.1016/j.ejphar.2008.11.057. Epub 2008 Dec 6.

PMID:
19087872
8.

Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion.

McDonald MC, Zacharowski K, Bowes J, Cuzzocrea S, Thiemermann C.

Free Radic Biol Med. 1999 Sep;27(5-6):493-503.

PMID:
10490268
9.

Tempol reduces reperfusion-induced arrhythmias in anaesthetized rats.

Guo R, Gao XY, Wang W, Wang HJ, Zhang F, Zhang Y, Zhu GQ.

Pharmacol Res. 2005 Aug;52(2):192-8.

PMID:
15967386
10.

Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol.

Kutala VK, Khan M, Mandal R, Potaraju V, Colantuono G, Kumbala D, Kuppusamy P.

J Cardiovasc Pharmacol. 2006 Sep;48(3):79-87.

PMID:
17031260
11.

Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts.

Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, Yamamoto T, Igawa O, Hisatome I, Shigemasa C.

Circ J. 2003 Sep;67(9):781-7.

12.

Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.

Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C.

Kidney Int. 2000 Aug;58(2):658-73.

13.

Effects of exogenous big endothelin-1 on postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.

Tawa M, Fukumoto T, Ohkita M, Yamashita N, Geddawy A, Imamura T, Ayajiki K, Okamura T, Matsumura Y.

Hypertens Res. 2011 Feb;34(2):218-24. doi: 10.1038/hr.2010.213. Epub 2010 Nov 4.

PMID:
21048781
14.
15.

PBN spin trapping of free radicals in the reperfusion-injured heart. Limitations for pharmacological investigations.

Vrbjar N, Zöllner S, Haseloff RF, Pissarek M, Blasig IE.

Mol Cell Biochem. 1998 Sep;186(1-2):107-15.

PMID:
9774191
16.

Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy.

Galang N, Sasaki H, Maulik N.

Toxicology. 2000 Aug 7;148(2-3):111-8.

PMID:
10962129
17.

Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart.

Naseem SA, Kontos MC, Rao PS, Jesse RL, Hess ML, Kukreja RC.

J Mol Cell Cardiol. 1995 Jan;27(1):419-26.

PMID:
7760362
18.

Postconditioning improves postischemic cardiac dysfunction independently of norepinephrine overflow after reperfusion in rat hearts: comparison with preconditioning.

Tawa M, Fukumoto T, Yamashita N, Ohkita M, Ayajiki K, Okamura T, Matsumura Y.

J Cardiovasc Pharmacol. 2010 Jan;55(1):6-13. doi: 10.1097/FJC.0b013e3181bfb1c1.

PMID:
19786893
19.

Increased endogenous ascorbyl free radical formation with singlet oxygen scavengers in reperfusion injury: an EPR and functional recovery study in rat hearts.

Lee JW, Bobst EV, Wang YG, Ashraf MM, Bobst AM.

Cell Mol Biol (Noisy-le-grand). 2000 Dec;46(8):1383-95.

PMID:
11156483
20.

Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation.

Yamada J, Yoshimura S, Yamakawa H, Sawada M, Nakagawa M, Hara S, Kaku Y, Iwama T, Naganawa T, Banno Y, Nakashima S, Sakai N.

Neurosci Res. 2003 Jan;45(1):1-8.

PMID:
12507718

Supplemental Content

Support Center